Internet-Based Nonsmoking Program for Postpartum Women (PostPartum_2)

November 10, 2015 updated by: Susan Schroeder, Oregon Center for Applied Science, Inc.
This project developed and evaluated an Internet-based interactive program with digital coaching designed to assist two groups of smokers in quitting smoking: (1) pregnant smokers and (2) general-population smokers (i.e., men and non-pregnant women). Program content was based on the U.S. Department of Health and Human Services Clinical Practice Guidelines, "Treating Tobacco Use and Dependence: 2008 Update" (Fiore et al., 2008) and input from project consultants.

Study Overview

Detailed Description

The "Break the Chain" program is an online smoking cessation intervention that incorporated strategic message construction based on behavior change constructs, interactive exercises, and digitial coaching support to engage the user in their smoking behavior change. The Expanded Theory of Reasoned Action (ETRA) (Fishbein, 1999, 2000) provides the theoretical foundation for the content. Intervention components include: (1) interactive check-ins, (2) content modules and interactive smoking cessation tools, (3) digital coaching, and (4) online social media (i.e., article feed).

Content modules included: Benefits of quitting, Making a plan for quitting, Boosting your support system, Planning for cravings and tempting situations, Managing stress and mood, Managing your weight, and Becoming an ex-smoker. Tailored information within each module was presented to the user based on responses to initial assessment questions and interactive check-ins (e.g., readiness to quit, pregnancy status, previous quit attempts, self-efficacy for quitting, worry about weight gain). Interactive tools presented within the logical flow of the modules included a Reasons for Quitting questionnaire, Pros and Cons of Quitting tool (decisional balance), Nicotine Dependence quiz, a Pharmacological Aid Decision tool, and a Quit Meter. Content was entirely text-based.

Within-program coach-generated and program-generated messages provided cessation tips and information. Digital coaching contacts were timed and tailored to the user's smoking status, health history, pregnancy status (if appropriate), and timing of quit day. The coaching messages prompted the user to engage more fully with the website by presenting hyperlinks to pertinent smoking cessation information or strategies in the program. A computer algorithm controlled the timing of the messages to each user. Users were invited to contact their coach via in-program message at any time with questions or concerns about smoking cessation strategies. A coaching interface allowed a health coach to view user information as the user progressed through the program and developed his/her quit plan. The coaching interface was also the platform through which the coach managed communication with each user.

Study Type

Interventional

Enrollment (Actual)

307

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oregon
      • Eugene, Oregon, United States, 97401
        • Oregon Center for Applied Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria for pregnant:

  • 18 years or older
  • Between 8 and 32 weeks pregnant
  • Currently smoking, trying to quit, or quit smoking within last 2 months
  • Able to speak and read English
  • Have access to high-speed or DSL Internet and email for the duration of the study.

Inclusion criteria for general population participants:

  • Male or female not pregnant
  • 18 years or older
  • Currently smoking, trying to quit, or quit smoking within last 2 months
  • Able to speak and read English
  • Have access to high-speed or DSL Internet and email for the duration of the study

Exclusion critieria:

  • Men and women under age 18 were excluded.
  • Women who were pregnant but whose pregnancy did not fit within the specified time frame were excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Break the Chain
Access during the evaluation study period to an Internet smoking cessation intervention that included digital coaching messages sent at prescribed times during the participant's quit process and as needed in response to participant questions or comments.
Internet-based smoking cessation intervention designed for general population smokers with targeted materials for pregnant women. The program included a digital coaching component delivered via email at specific points as the user progresses through his/her quit process. Program content is based on Department of Health and Human Services Clinical Practice Guidelines for Treating Tobacco Use and Dependence.
Active Comparator: Clearing the Air PDF
Control users were e-mailed a copy of the National Cancer Institute's PDF smoking cessation booklet, "Clearing the Air."
PDF version of smoking cessation booklet from National Cancer Institute.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in number of cigarettes smoked in the last 7 days
Time Frame: 10 months
Smoking cessation as measured by number of cigarettes smoked in the last 7 days. We will use an intent-to-treat statistical analysis, a conservative approach that classifies all non-responders as smokers.
10 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in knowledge of impact of smoking cessation
Time Frame: 10 months
Pregnant smokers only: Eight knowledge items assess post-natal impact (e.g., Smoking during pregnancy increases chances of having a child who develops asthma); seven items assess infant impact (e.g., Exposing an infant to smoke in the home increases the chances the baby will wake up at night more than usual); eight items assessed infant health risk (e.g., Babies exposed to secondhand smoke have increased chances of having learning disabilities). Response options were a "true" and "false" format scored to reflect the proportion of items answered correct in each domain. The seriousness of infant health issues related to smoking was assessed with five items (e.g., A baby born with lower than normal weight - low birth weight baby) with a five-point response option (1=not at all serious, 5=extremely serious). A mean score was computed and it showed good reliability (alpha = .82).
10 months
Change from baseline in self-efficacy to quit smoking
Time Frame: 10 months
Six self-efficacy items (e.g., How confident are you that you could quit and stay quit) were assessed of all smokers. Each item had a five-point response option (1=not at all confident, 5=extremely confident) and showed good reliability (alpha=.86).
10 months
Change from baseline in attitudes about smoking cessation
Time Frame: 10 months
Five attitude items (e.g., Knowing the right way to ask for help from family and friends when I'm quitting is important) were assessed of all smokers. Each item had a five-point response option (1=not at all important, 5=extremely important) and showed adequate reliability (alpha=.77).
10 months
Change from baseline in behavioral intentions about smoking cessation
Time Frame: 10 months
Five intention items (e.g., How likely is it that you will avoid every situation where you will be tempted to smoke) were assessed of all smokers. Each item had a five-point response option (1=not at all likely, 5=extremely likely) and showed adequate reliability (alpha = .79).
10 months
Program satisfaction
Time Frame: 4-week posttest
Seven program satisfaction items were assessed of as rated by the treatment participants at the T2 assessment. Treatment participants were also asked how likely they would be to recommend the program to a friend and/or family member.
4-week posttest
User rating of system usability
Time Frame: 4-week posttest
All treatment participants were asked how much they agreed or disagreed with program usability statements (see Table 3) with response options on a 5- point scale (1 = strongly disagree, 2 = disagree, 3 = neither disagree or agree, 4 = agree 5 = strongly agree). The SUS is a tool designed for assessing the usability of a product and has been normed across numerous platforms (e.g., Web sites, cell phones, TV applications). Scores range from 0 to 100. (SUS; Bangor, Kortum, & Miller, 2009)
4-week posttest

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Susan W Schroeder, MPH, MCHES, Oregon Center for Applied Science

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

August 1, 2013

Study Completion (Actual)

August 1, 2013

Study Registration Dates

First Submitted

January 2, 2015

First Submitted That Met QC Criteria

November 10, 2015

First Posted (Estimate)

November 11, 2015

Study Record Updates

Last Update Posted (Estimate)

November 11, 2015

Last Update Submitted That Met QC Criteria

November 10, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • SBIR80RR-II
  • R44CA112739-01A2 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cigarette Smoking

Clinical Trials on Break the Chain

Subscribe